Cannabis use and involuntary admission may mediate long-term adherence in first-episode psychosis patients: a prospective longitudinal study

被引:31
|
作者
Barbeito, Sara [1 ]
Vega, Patricia [1 ]
Ruiz de Azua, Sonia [1 ,3 ]
Saenz, Margarita [1 ]
Martinez-Cengotitabengoa, Monica [1 ,2 ]
Gonzalez-Ortega, Itxaso [1 ,3 ]
Bermudez, Cristina [1 ]
Hernanz, Margarita [1 ]
Fernandez de Corres, Blanca [1 ]
Gonzalez-Pinto, Ana [1 ,3 ,4 ]
机构
[1] Univ Hosp Alava, Biomed Res Ctr Mental Hlth Net CIBERSAM, Vitoria, Spain
[2] UNED, Madrid, Spain
[3] Univ Basque Country, Leioa 48940, Bizkaia, Spain
[4] Hosp Santiago, CIBERSAM G10, Dept Psychiat, Vitoria, Spain
来源
BMC PSYCHIATRY | 2013年 / 13卷
关键词
Adherence; Cannabis; First psychotic episode; Involuntary admission; 1ST EPISODE SCHIZOPHRENIA; 2-YEAR FOLLOW-UP; RATING-SCALE; MEDICATION ADHERENCE; RISK-FACTORS; PREDICTORS; DISORDERS; IMPACT; NONADHERENCE; HOSPITALIZATION;
D O I
10.1186/1471-244X-13-326
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Background: This study aimed to examine factors associated with treatment adherence in first-episode psychosis (FEP) patients followed up over 8 years, especially involuntary first admission and stopping cannabis use. Methods: This prospective, longitudinal study of FEP patients collected data on symptoms, adherence, functioning, and substance use. Adherence to treatment was the main outcome variable and was categorized as 'good' or 'bad'. Cannabis use during follow-up was stratified as continued use, stopped use, and never used. Bivariate and logistic regression models identified factors significantly associated with adherence and changes in adherence over the 8-year follow-up period. Results: Of the 98 FEP patients analyzed at baseline, 57.1% had involuntary first admission, 74.4% bad adherence, and 52% cannabis use. Good adherence at baseline was associated with Global Assessment of Functioning score (p = 0.019), Hamilton Depression Rating Scale score (p = 0.017) and voluntary admission (p < 0.001). Adherence patterns over 8 years included: 43.4% patients always bad, 26.1% always good, 25% improved from bad to good. Among the improved adherence group, 95.7% had involuntary first admission and 38.9% stopped cannabis use. In the subgroup of patients with bad adherence at baseline, involuntary first admission and quitting cannabis use during follow up were associated with improved adherence. Conclusions: The long-term association between treatment adherence and type of first admission and cannabis use in FEP patients suggest targets for intervention to improve clinical outcomes.
引用
收藏
页数:9
相关论文
共 50 条
  • [31] Early Medication Discontinuation on Long-term Recovery Outcome in First-Episode Psychosis
    Hui, Christy L. M.
    Chen, Eric Y. H.
    JAMA PSYCHIATRY, 2014, 71 (02) : 207 - 208
  • [32] Impact of previous tobacco use with or without cannabis on first psychotic experiences in patients with first-episode psychosis
    Gonzalez-Blanco, Leticia
    Paz Garcia-Portilla, Maria
    Gutierrez, Miguel
    Mezquida, Gisela
    Cuesta, Manuel J.
    Urbiola, Elena
    Amoretti, Silvia
    Barcones, Fe
    Gonzalez-Pinto, Ana
    Pina-Camacho, Laura
    Corripio, Iluminada
    Vieta, Eduard
    Baeza, Immaculada
    Toll, Alba
    Saiz, Pilar A.
    Bobes, Julio
    Bernardo, Miguel
    SCHIZOPHRENIA RESEARCH, 2021, 236 : 19 - 28
  • [33] Impact of previous tobacco use with or without cannabis on first psychotic experiences in patients with first-episode psychosis
    Gonzalez-Blanco, L.
    Garcia-Portilla, M. P.
    Gutierrez, M.
    Mezquida, G.
    Cuesta, M. J.
    Urbiola, E.
    Amoretti, S.
    Barcones, F.
    Gonzalez-Pinto, A.
    Pina-Camocha, L.
    Corripio, I.
    Vieta, E.
    Baeza, I.
    Toll, A.
    Saiz, P. A.
    Bobes, J.
    Bernardo, M.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2020, 40 : S281 - S282
  • [34] Behind the heterogeneity in the long-term course of first-episode psychosis: Different psychotic symptom trajectories are associated with different patterns of cannabis and stimulant use
    Kreis, Isabel
    Lagerberg, Trine Vik
    Wold, Kristin Fjelnseth
    Asbo, Gina
    Simonsen, Carmen
    Flaaten, Camilla Barthel
    Engen, Magnus Johan
    Lyngstad, Siv Hege
    Widing, Line Hustad
    Ueland, Torill
    Melle, Ingrid
    SCHIZOPHRENIA RESEARCH, 2024, 271 : 91 - 99
  • [35] DOES MEDICATION EFFICACY PREDICT ADHERENCE IN FIRST EPISODE PSYCHOSIS? A LONGITUDINAL PROSPECTIVE STUDY
    Steger, Katherine
    Cassidy, C.
    Rabinovitch, M.
    Joober, R.
    Malla, A.
    SCHIZOPHRENIA BULLETIN, 2009, 35 : 315 - 315
  • [36] Prospective Long-Term Cohort Study of Subjects With First-Episode Psychosis Examining Eight Major Outcome Domains and Their Predictors: Study Protocol
    Peralta, Victor
    Moreno-Izco, Lucia
    Garcia de Jalon, Elena
    Sanchez-Torres, Ana M.
    Janda, Lucia
    Peralta, David
    Fananas, Lourdes
    Cuesta, Manuel J.
    FRONTIERS IN PSYCHIATRY, 2021, 12
  • [37] Negative association between neurological soft signs and cannabis use in first-episode psychosis patients
    Mhalla, A.
    Essid, N.
    Gassab, L.
    Mechri, A.
    Gaha, L.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2014, 24 : S699 - S699
  • [38] Empirical validity of Leonhard's psychoses: A long-term follow-up study of first-episode psychosis patients
    Cuesta, M. J.
    Sanchez-Torres, A. M.
    de Jalon, E. Garcia
    Moreno-Izco, L.
    Gil-Berrozpe, G. J.
    Zarzuela, A.
    Papiol, S.
    Fananas, L.
    Peralta, V.
    SCHIZOPHRENIA RESEARCH, 2024, 263 : 237 - 245
  • [39] Long-Term Effect of Haloperidol, Olanzapine, and Risperidone on Plasma Prolactin Levels in Patients With First-Episode Psychosis
    Perez-Iglesias, Rocio
    Mata, Ignacio
    Martinez-Garcia, Obdulia
    Teresa Garcia-Unzueta, M.
    Antonio Amado, Jose
    Valdizan, Elsa M.
    Luis Vazquez-Barquero, Jose
    Crespo-Facorro, Benedicto
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2012, 32 (06) : 804 - 808
  • [40] Variations in Disrupted-in-Schizophrenia 1 gene modulate long-term longitudinal differences in cortical thickness in patients with a first-episode of psychosis
    Javier Vázquez-Bourgon
    Roberto Roiz-Santiañez
    Sergi Papiol
    Adele Ferro
    Noemí Varela-Gómez
    Lourdes Fañanás
    Benedicto Crespo-Facorro
    Brain Imaging and Behavior, 2016, 10 : 629 - 635